Hedonic shopping experience, subjective well-being and brand luxury: a comparative discussion of physical stores and e-retailers

PurposeThe study explores the influence of shopping channels on the hedonic shopping experience, contributing to subjective well-being (SWB) based on the purchased branded product. It also assesses the variations in these effects according to brand luxury. The purpose of the paper is to provide strategic suggestions for building luxury apparel distribution tactics that balance maintaining brand luxury with business growth through both physical stores and digital stores (e-retail).Design/methodology/approachBased on 418 samples collected in Japan, consumers' perceptions of hedonic shopping value and SWB are examined according to two channel factors, such as physical retail vs e-retail and mono-brand stores vs multi-brand stores. Additionally, the moderation effects of brand luxury are discussed.FindingsMulti-group path analyses reveal that physical mono-brand stores contribute to hedonic shopping value. In addition, this experiential value is found to increase SWB, especially when the brand luxury level is high.Practical implicationsThese findings suggest that managers should place a high level of importance on consumers' shopping experiences via physical direct retail especially in the case of a higher luxury level, even in today's highly developed digital environment.Originality/valueThe current study uniquely discusses the effects of shopping channels and experiences on SWB based on an acquired branded product, i.e., an evaluation of the outcome of shopping behavior and product acquisition. The study also reinforces the importance of physical stores suggested in previous luxury research.

Evaluating Real-World Effectiveness and Safety of Generic and Brand-Name Imatinib in Chronic Myeloid Leukemia

Introduction: Generic formulations of imatinib were approved and commercially available in the United States starting in 2016, introducing vast cost savings to the standard treatment of chronic myeloid leukemia (CML). While bioequivalence studies of generic formulations are required for Food and Drug Administration approval, the safety of generic drug supply chains have come into question. There is limited real-world data comparing the effectiveness and safety profiles of generic formulations to the original. This study aimed to evaluate the effectiveness and safety of generic imatinib compared to the branded product. Methods: This retrospective study included patients treated at UNC Medical Centers who were diagnosed with CML and treated with imatinib at any time during their course of treatment. Data was retrieved from the institution's electronic health record and collected over the first 6 months of imatinib treatment to include both safety and effectiveness outcomes. The primary endpoint was to compare generic versus branded product effectiveness, as defined by the European LeukemiaNet (ELN) guidelines (achieving BCR-ABL/ABL ratio of <10% and <1% at 3 and 6 months, respectively). The secondary endpoints included comparisons of generic vs branded product safety, measured via patient adverse drug events (ADEs), all-cause hospitalizations, and early treatment discontinuation. Patients were excluded from primary endpoint evaluation and only included for safety endpoint analysis if they were not treated with imatinib first-line and if duration of imatinib treatment was less than 6 months. Results: Fifty-one CML patients met criteria with no significant differences in age or gender between the generic (n = 23) and brand (n = 28) imatinib groups (Table 1). First-line therapy was composed of 83% of patients on generic imatinib and 29% of patients on brand imatinib. Of those receiving first-line imatinib therapy, there was no difference in molecular responses at 3 and 6 months between generic and brand imatinib (p = 0.71). Brand imatinib was associated with numerically lower CML-related emergency department visits and hospitalizations when compared to generic imatinib, although this difference was not statistically significant (p = 0.12). Rates of discontinuation were numerically lower for brand imatinib although overall time to discontinuation was shorter for generic imatinib (Table 1). Conclusions: This study demonstrates real-world treatment effectiveness and safety of generic and brand imatinib in clinical practice. Generic imatinib appears to be associated with higher rates of CML-related ED visits and hospitalizations although sample size was small and statistical significance was not reached. Further analyses of comparisons and continuation of data collection will provide a more robust assessment to compare the effectiveness and safety of generic and brand imatinib in the real-world setting. Figure 1 Figure 1. Disclosures Muluneh: Novartis: Other: Spouse works for Novartis.

TP8.2.18 Every little helps. A trainee led cost saving initiative

Aim The NHS is under pressure to deliver the best quality care within a confined budget. The cost of spending on medications is growing by 12% per annum. The five year forward plan for the NHS called for £22 Billion in efficiency savings. All NHS staff are being asked to help deliver better outcomes at lower costs. We aimed to review costs in the surgical department, identify savings, implement changes and evaluate the outcome. Method Pharmacy orders from 2016-17 were reviewed. Prices of branded and generic medications were compared. Levobupivicaine was identified as a product with cost savings between branded and generic forms. Procurement officers were advised to switch to generic alternatives and the pharmacy system was adjusted to highlight that generic forms should be ordered. Orders for 2018-19 were reviewed and savings calculated. Results 29,280 units of levobupivicaine were ordered in 2016-17. 100% of these orders were of the branded product. Projected savings of switching to a generic product was £12,846 per annum. 31,355 units of levobupivicaine were purchased during the 2018-19 period. 83% of orders were for the generic product. £11,805 was saved over this period. £1,703 of further savings have been highlighted. Conclusion We have shown that simple changes can result in modest savings. All NHS staff, including trainees, can lead cost reducing initiatives. Multiple small savings will summate to larger savings, resulting in resources being better utilised to improve patient outcomes.

Effect of Co-branding Strategy Elements on Consumer Attitude and Purchase Intention : A Study in Indonesia

According to brand alliance literature, the compatibility of both brand characteristics in co-branded products will raise consumer positive attitude and purchase intention. Previous researches have explored co-branding strategy between the same sector or complement product character from different sector. However, few researchs have conducted exploration of the co-branding strategy in a different sector with less complement character. This study seeks to construct the value of co-branding strategy influencing female consumer attitude as well as purchase intention where the less-known Indonesian cosmetics brand who invite well-known food brands to create blended characteristics of cosmetic products. Three co-branded products namely Mizzu Cosmetics x Khong Guan Biscuits, Dear Me Beauty x Yupi, Dear Me Beauty x Sasa, Dear Me Beauty x Nissin as the object of research. A total of 358 questionnaires were distributed to female cosmetic consumers aged between 19-41. The proposed research model has been tested using PLS-SEM. The finding highlight prior attitude toward host brand appear weak to influence attitude toward co-branded. However, brand fit could mediate prior attitude toward host brand in influencing atittude toward co-branded. Mediating roles of brand fit, attitude toward co-brand, and post-attitude toward host brand appear important in the element of consumer attitude and purchase intention. A well-known and suitable co-branding partner is needed to give exposure to the co-branded product and provide a spill-over effect for the host brands. This study contribute to add spill-over effect phenomenon in brand alliance literatures.

Community Consumption of Traditional Medicine and Health Supplements During the Coronavirus Disease-2019 Pandemic

Coronavirus disease-2019 (COVID-19) encourages the community to prioritize basic and personal health needs. This study aimed to explore the consumer behaviour of traditional medicine and health supplements during the COVID-19 pandemic in Indonesia using the Consumer Decision Model approach. A quick online cross-sectional survey involving 215 respondents was carried out from December 23, 2020, until January 2, 2021. This study revealed that the majority of respondents consume the products as forced by the pandemic situation, and their use has increased than before the pandemic. The primary reason for consuming the product is to increase their immunity during a pandemic, and they felt more healthy after consuming it. Social media and television are the primary sources of product information. Furthermore, we found that the majority of respondents were branded product consumers. Respondents were more likely to have good behaviour based on knowledge of the products' legality, dosage, indication, instructions for use, and expiration date. This study sets appropriate consumer behaviour and performs the statistical tests only for branded product consumers. It is concluded that consumer behaviour in this study is related to product advertisement exposure and acceptance, environmental influence, and individual difference.

EXPRESS: The Power of Brand Selfies

Smartphones have made sharing images of branded experiences nearly effortless. This research classifies social media brand imagery and studies user response. Aside from packshots (standalone product images), two types of brand-related selfie images appear online: consumer selfies (featuring brands and consumers' faces) and an emerging phenomenon we term brand selfies (invisible consumers holding a branded product). We use convolutional neural networks to identify these archetypes and train language models to infer social media response to more than a quarter million brand-image posts (185 brands on Twitter and Instagram). We find consumer-selfie images receive more sender engagement (i.e., likes and comments), whereas brand selfies result in more brand engagement, expressed by purchase intentions. These results cast doubt on whether conventional social media metrics are appropriate indicators of brand engagement. Results for display ads are consistent with this observation, with higher click-through rates for brand selfies than for consumer selfies. A controlled lab experiment suggests self-reference is driving the differential response to selfie images. Collectively, these results demonstrate how (interpretable) machine learning helps to extract marketing-relevant information from unstructured multimedia content and that selfie images are a matter of perspective in terms of actual brand engagement.

Celebrity Brand Fashion Collaborations In A Canadian Context

Celebrity branded collections are an interesting niche segment of the fashion industry and they have yet to be examined within a Canadian context. This research identifies factors that influence celebrity brand collaborations utilizing a mixed methods approach. Content analysis of merchandise featured on four websites of Canadian celebrities identified key features of celebrity branded product assortments. Interviews with a fashion broker and celebrity fashion editor unpacked the nuances of the design process. The evidence from this study suggests that the design process is negotiated, both the celebrity and the brand play vital roles in product development. The findings derived from the content analysis established the type of garments and accessories, fabrics, colours, patterns, motifs and slogans, logos, fit, sizes, and price points that are commonly used in celebrity fashion collections. Given the huge economic power of celebrity branded collections, this research outlines important practices for designers, product developers and celebrities.

Celebrity Brand Fashion Collaborations In A Canadian Context

Celebrity branded collections are an interesting niche segment of the fashion industry and they have yet to be examined within a Canadian context. This research identifies factors that influence celebrity brand collaborations utilizing a mixed methods approach. Content analysis of merchandise featured on four websites of Canadian celebrities identified key features of celebrity branded product assortments. Interviews with a fashion broker and celebrity fashion editor unpacked the nuances of the design process. The evidence from this study suggests that the design process is negotiated, both the celebrity and the brand play vital roles in product development. The findings derived from the content analysis established the type of garments and accessories, fabrics, colours, patterns, motifs and slogans, logos, fit, sizes, and price points that are commonly used in celebrity fashion collections. Given the huge economic power of celebrity branded collections, this research outlines important practices for designers, product developers and celebrities.